References
- Belham C, Comb MJ and Avruch J (2001) Identification of the NIMA family kinases NEK6/7 as regulators of the p70 ribosomal S6 kinase. Curr BioI 11: 1155-1167 https://doi.org/10.1016/S0960-9822(01)00369-4
- Belham C, Roig J, Caldwell JA, Aoyama Y, Kemp BE, Comb M and Avruch J (2003) A mitotic cascade of NIMA family kinases. NercclINek9 activates the Nek6 and Nek7 kinases. J BioI Chem 278: 34897-34909 https://doi.org/10.1074/jbc.M303663200
- Bischof O, Schwamborn K, Martin N, Werner A, Sustmann C, Grosschedl R and Dejean A (2006) The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol Cell 22: 783-794 https://doi.org/10.1016/j.molcel.2006.05.016
- Boggio R, Colombo R, Hay RT, Draetta GF and Chiocca S (2004) A mechanism for inhibiting the SUMO pathway. Mol Cell 16: 549-561 https://doi.org/10.1016/j.molcel.2004.11.007
- Bohren KM, Nadkami V, Song JR, Gabbay KH and Owerbach D (2004) A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. J BioI Chem 279: 27233-27238 https://doi.org/10.1074/jbc.M402273200
- Dorval V and Fraser PE (2006) Small ubiquitin-like modifier (SUMO) modification ofnatlvely unfolded proteins Tau and alpha-synuclein. J BioI Chem 281: 9919-9924 https://doi.org/10.1074/jbc.M510127200
- Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, Solomon E, de The H, Hay RT and Freemont PS (1999) SUMO-l modification of the acute promyelocytic leukemia protein PML: implications for nuclear localization. J Cell Sci 112: 381-393
- Gill G (2004) SUMO and ubiquitin in the nucleus: different fimctions, similar mechanisms?. Genes Dev 18: 2046-2059 https://doi.org/10.1101/gad.1214604
- Hashimoto Y, Akita H, Hibino M, Kohri K and Nakanishi M (2002) Identification and characterization of Nek6 protein kinase, a potential human homolog of NIMA histone H3 kinase. Biochem Biophys Res Commun 293: 753-758 https://doi.org/10.1016/S0006-291X(02)00297-8
- Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A and Sistonen L (2006) PDSM, a motif for SUMOylation-dependent SUMO modification. Proc Natl Acad Sci USA 103: 45-50
- Kagey MH, Melhuish TA and Wotton D (2003) The polycomb protein Pc2 is a SUMO E3. Cell 113: 127-137 https://doi.org/10.1016/S0092-8674(03)00159-4
- Kandli M, Feige E, Chen A, Kilfm G and Motro B (2000) Isolation and characterization of two evolutionarily conserved murine kinases (Nek6 and nek7) related to the fungal mitotic regulator, NIMA. Genomics 68: 187-196 https://doi.org/10.1006/geno.2000.6293
- Kikuchi A, Kishida S and Yamamoto H (2006) Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Exp Mol Med 38: 1-10 https://doi.org/10.1038/emm.2006.1
- Lizcano JM, Deak M, Morrice N, Kieloch A, Hastie CJ, Dong L, Schutkowski M, Reimer U and Alessi DR (2002) Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum-and glucocorticoid-induced protein kinase in vivo. J BioI Chem 277: 27839-27849 https://doi.org/10.1074/jbc.M202042200
- Malumbres M and Barbacid M (2007) Cell cycle kinases in cancer. Curr Opin Genet Dev 17: 60-65 https://doi.org/10.1016/j.gde.2006.12.008
- Melchior F and Hengst L (2002) SUMO-1 and p53. Cell Cycle 1: 245-249
- Minoguchi S, Minoguchi M and Yoshimura A (2003) Differential control of the NIMA-related kinases, Nek6 and Nek7, by serum stimulation. Biochem Biophys Res Cornrnun 301: 899-906 https://doi.org/10.1016/S0006-291X(03)00049-4
- Pichler A, Gast A, Seeler JS, Dejean A and Melchior F (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108: 109-120 https://doi.org/10.1016/S0092-8674(01)00633-X
- Quannby LM and Mahjoub MR (2005) Caught Nek-ing: cilia and centrioles. J Cell Sci 118: 5161-5169 https://doi.org/10.1242/jcs.02681
- Roig J, Mikhailov A, Belham C, and Avruch J (2002) Nerccl, a mammalian NIMA-family kinase, binds the Ran GTPase and regulates mitotic progression. Genes Dev 16: 1640-1658 https://doi.org/10.1101/gad.972202
- Sampson DA, Wang M and Matunis MJ (2001) The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J BioI Chem 276: 23164-23169
- van Waardenburg RC, Duda DM, Lancaster CS, Schulman BA and Bjornsti MA (2006) Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress. Mol Cell BioI 26: 4958-4969 https://doi.org/10.1128/MCB.00160-06
- Vega FM, Sevilla A and Lazo PA (2004) p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1. Mol Cell BioI 24: 10366-10380 https://doi.org/10.1128/MCB.24.23.10366-10380.2004
- Wilson VG and Rangasamy D (2001) Intracellular targeting of proteins by sumoylation. Exp Cell Res 271: 57-65 https://doi.org/10.1006/excr.2001.5366
- Yang SH, Galanis A, Witty J and Sharrocks AD (2006) An extended consensus motif enhances the specificity of substrate modification by SUMO. EMBO J 25: 5083-5093 https://doi.org/10.1038/sj.emboj.7601383
- Yin MJ, Shao L, Voehringer D, Smeal T and Jallal B (2003) The serine/threonine kinase Nek6 is required for cell cycle progression through mitosis. J BioI Chem 278: 52454-52460 https://doi.org/10.1074/jbc.M308080200
- Zhang H., Saitoh Hand Matunis MJ (2002) Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex. Mol Cell BioI 22: 6498-6508 https://doi.org/10.1128/MCB.22.18.6498-6508.2002